2000

Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) - Previous Issues

Volume 2, Issue 1

Volumes & issues

Most Cited Most Cited RSS feed

- Quilizumab is an Afucosylated Humanized Anti-M1 Prime Therapeutic Antibody
  
  Authors: Hans D. Brightbill, Yuwen L. Lin, Zhonghua Lin, Martha Tan, Y. Gloria Meng, Mercedesz Balazs, Shan Chung and Lawren C. Wu
- Hydrogen Sulfide: A New Tool to Design and Develop Drugs
  
  Authors: Nethaji Muniraj, Abel Damien Ang, Alireza Badiei, Jack Rivers-Auty and Madhav Bhatia
- Cells and Mediators of Inflammation in Acute Pancreatitis
  
  Authors: Ramesh Kumar and Madhav Bhatia
- Synthesis and Pharmacological Studies of Novel 3-Substituted Indole Derivatives as Potential Anti-Inflammatory and Analgesic Agents
  
  Authors: Mayura A.Kale, Ashok S. Narute and Tukaram M. Kalyankar
- Randomized, Placebo Controlled Study of the Effects of Etoricoxib on Markers of Inflammation, Pain and Muscle Force After Eccentric Exercise
  
  Authors: Matthias Rother, Egbert Johannes Seidel, Ilka Rother and Steffen Koll
- Effect of Early Treatment of Newborns by Peroral Colonization Using Non-pathogenic E. coli on the Development of Their Immuno- allergic System
  
  Authors: Jiri Liska, Konrad Siala, Vaclav Holecek, Stepanka Sobotova, Monika Kepkova and RNDr. Ing. Frantisek Sefrna
More Less

This is a required field

Please enter a valid email address

Approval was a Success

Invalid data

An Error Occurred

Approval was partially successful, following selected items could not be processed due to error

Please enter a valid_number test